How It Works
Pharmacology research. This hub organizes the topic into a starting point, core reading, and deeper reference material so mobile readers and search systems can understand the page pathway quickly.
Get oriented first
Begin with the plain-language framing before reading narrower claims or legal and safety details.
Read the central articles
Use the core set to understand the topic before moving into edge cases and supporting references.
Education, not instruction
This section does not provide medical, dosing, sourcing, purchasing, or legal advice.
How psilocybin works: conversion to psilocin, 5-HT2A agonism, default mode network modulation, and the gap between mechanism and a demonstrated microdose effect.
How psilocybin may drive lasting change by reshaping neural connections and quieting the default mode network — strong preclinically, thin at microdose level.
Psilocybin to Psilocin: The Pharmacokinetics of a ProdrugPsilocybin is inactive until converted to psilocin: how conversion, absorption, and clearance work, and why dose-by-weight poorly predicts what reaches the brain.
The 5-HT2A Mechanism: How Psilocin Engages the Serotonin SystemPsilocin acts mainly as a 5-HT2A receptor agonist — the core of psychedelic pharmacology — and why full-dose receptor data don't settle what a microdose does.
Why a coherent mechanism makes microdosing plausible but can't show a sub-perceptual dose works — mechanism is not efficacy, and reports are not outcomes.